Hyperlipidemia and Pulmonary Embolism Risk

Understanding Risk Factors for PE

The European Society of Cardiology (ESC) guidelines categorize risk factors for venous thromboembolism (VTE) into strong, moderate, and weak categories, with strong risk factors (OR >10) including fractures, hospitalization for heart failure or atrial fibrillation, hip/knee replacement, major trauma, myocardial infarction, previous VTE, and spinal cord injury 3, 1
Moderate risk factors (OR 2-9) include arthroscopic knee surgery, autoimmune diseases, central venous lines, chemotherapy, heart failure, hormone therapy, and cancer 1
Weak risk factors (OR <2) include bed rest, diabetes mellitus, arterial hypertension, immobility, increasing age, laparoscopic surgery, obesity, pregnancy, and varicose veins 2
The ESC guidelines note that cardiovascular risk factors, such as hyperlipidemia, may be associated with VTE, but this is likely an indirect association mediated through complications of coronary artery disease 1, 2

VTE may be viewed as part of the cardiovascular disease continuum, with some shared risk factors with arterial disease 4
The ESC guidelines state that the association between cardiovascular risk factors and VTE may be indirect, mediated by complications of coronary artery disease and cancer 1, 2
Myocardial infarction and heart failure, which can result from untreated hyperlipidemia, increase the risk of PE, suggesting an indirect pathway 1

When assessing PE risk, clinicians should focus on established strong and moderate risk factors outlined in the ESC guidelines, rather than hyperlipidemia alone 3, 1
Managing hyperlipidemia remains important for overall cardiovascular health and may indirectly reduce PE risk by preventing conditions like myocardial infarction and heart failure that are direct risk factors 1, 2
PE prevention strategies should focus on addressing established direct risk factors rather than hyperlipidemia management specifically for PE prevention 3, 1